Hospice and Palliative Care - Dyspnoea Treatment

Identifying Attributes

Care Settings
Palliative Care
Country
United States of America
Publishing Organisation
Prepare, Embrace, Attend, Communicate, Empower (PEACE) Hospice and Palliative Care Quality Measures
Type of Quality Indicator
Process
IOM Quality Dimension
Effectiveness
Domain
Physical Aspects of Care

Defining Attributes

Definition

For patients who screened positive for dyspnoea, the percent who receive medication or non-medication treatment within 24 hours of screening.

Numerator

Patients who screened positive for dyspnoea who received treatment within 24 hours of screening. Treatment is administered if within 24 hours of the positive screen for dyspnoea, medical treatment plan, orders or pharmacy records show inhaled medications, steroids, diuretics, or non-medication strategies such as oxygen and energy conservation. Treatment may also include benzodiazepine or opioid if clearly prescribed for dyspnoea.

Denominator

Patients enrolled in hospice for 7 or more days OR patients receiving palliative care who report dyspnoea when dyspnoea screening is done on the admission evaluation / initial encounter.

Exclusions

Denominator Exclusions: Palliative care patients with length of stay < 1 day or hospice patients with length of stay < 7 days, patients who were not screened for dyspnoea, and/or patients with a negative screening. Calculations required to perform denominator exclusions: Discharge date – admission date = 1 or hospice patients with discharge date – admission date = 7.

Use of Risk Adjustment
No
Risk Adjustments

None

Stratifications

None

Collection and Reporting Attributes

Type of Data Collection
Standardised clinical data
Data Collection Methods

Data Source: Electronic Clinical Data. Hospice and palliative care: consecutive sample of equal numbers of admissions + decedents beginning with randomly selected date; minimum sample size 100. Data collection using a structured chart abstraction tool and operational definition.

Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods

The Level of Analysis is performed at the Clinician (Group/Practice) and Facility levels.

Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No

Source and Reference Attributes

Evidence Source

Indicator development: Anna P. Schenck, Franziska S. Rokoske, Danielle D. Durham, John G. Cagle, and Laura C. Hanson. The PEACE Project: Identification of Quality Measures for Hospice and Palliative Care.Journal of Palliative Medicine.Dec 2010.1451-1459.http://doi.org/10.1089/jpm.2010.0238 Indicator feasbility/testing: Hanson LC, Rowe C, Wessell K, et al. Measuring palliative care quality for seriously ill hospitalized patients. J Palliat Med 2012;15(7):798-804. PEACE website: www.med.unc.edu/pcare/about-palliative-care/resources/peace-quality-measures/

Technical Specifications

Full specifications were taken from NQF documentation available here: www.med.unc.edu/pcare/wp-content/uploads/sites/503/2017/11/nqf-dyspnea-treatment.pdf Unable to locate from PEACE program literature. Limited specification details available in Table 2 of Hanson LC, Rowe C, Wessell K, et al. Measuring palliative care quality for seriously ill hospitalized patients. J Palliat Med 2012;15(7):798-804. PEACE website: www.med.unc.edu/pcare/about-palliative-care/resources/peace-quality-measures/

Link to Measurement Tools

Linked to: NQF measure #1638 (endorsement status for this indicator was removed on 17 November 2021) and is paired with #1640 Hospice and Palliative Care - Dyspnea Screening and Dyspnea Treatment. This measure is part of a composite measure: Paired with Hospice and Palliative Care – Dyspnea Screening.

Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
No
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
02 December 2025